Differential	O
regulation	O
of	O
4E-BP1	B-protein
and	O
4E-BP2	B-protein
,	O
two	O
repressors	O
of	O
translation	O
initiation	O
,	O
during	O
human	B-cell_type
myeloid	I-cell_type
cell	I-cell_type
differentiation	O
.	O

Human	O
myeloid	O
differentiation	O
is	O
accompanied	O
by	O
a	O
decrease	O
in	O
cell	O
proliferation	O
.	O

Because	O
the	O
translation	O
rate	O
is	O
an	O
important	O
determinant	O
of	O
cell	O
proliferation	O
,	O
we	O
have	O
investigated	O
translation	O
initiation	O
during	O
human	B-cell_type
myeloid	I-cell_type
cell	I-cell_type
differentiation	O
using	O
the	O
HL-60	B-cell_line
promyelocytic	I-cell_line
leukemia	I-cell_line
cell	I-cell_line
line	I-cell_line
and	O
the	O
U-937	B-cell_line
monoblastic	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

A	O
decrease	O
in	O
the	O
translation	O
rate	O
is	O
observed	O
when	O
the	O
cells	O
are	O
induced	O
to	O
differentiate	O
along	O
the	O
monocytic/macrophage	O
pathway	O
or	O
along	O
the	O
granulocytic	O
pathway	O
.	O

The	O
inhibition	O
in	O
protein	O
synthesis	O
correlates	O
with	O
specific	O
regulation	O
of	O
two	O
repressors	O
of	O
translation	O
initiation	O
,	O
4E-BP1	B-protein
and	O
4E-BP2	B-protein
.	O

Induction	O
of	O
HL-60	B-cell_line
and	O
U-937	B-cell_line
cell	O
differentiation	O
into	O
monocytes/macrophages	B-cell_type
by	O
IFN-gamma	B-protein
or	O
PMA	O
results	O
in	O
a	O
dephosphorylation	O
and	O
consequent	O
activation	O
of	O
4E-BP1	B-protein
.	O

Dephosphorylation	O
of	O
4E-BP1	B-protein
was	O
also	O
observed	O
when	O
U-937	B-cell_line
cells	I-cell_line
were	O
induced	O
to	O
differentiate	O
into	O
monocytes/macrophages	B-cell_type
following	O
treatment	O
with	O
retinoic	O
acid	O
or	O
DMSO	O
.	O

In	O
contrast	O
,	O
treatment	O
of	O
HL-60	B-cell_line
cells	I-cell_line
with	O
retinoic	O
acid	O
or	O
DMSO	O
,	O
which	O
results	O
in	O
a	O
granulocytic	O
differentiation	O
of	O
these	O
cells	O
,	O
decreases	O
4E-BP1	B-protein
amount	O
without	O
affecting	O
its	O
phosphorylation	O
and	O
strongly	O
increases	O
4E-BP2	B-protein
amount	O
.	O

Taken	O
together	O
,	O
these	O
data	O
provide	O
evidence	O
for	O
differential	O
regulation	O
of	O
the	O
translational	O
machinery	O
during	O
human	O
myeloid	O
differentiation	O
,	O
specific	O
to	O
the	O
monocytic/macrophage	O
pathway	O
or	O
to	O
the	O
granulocytic	O
pathway	O
.	O

3	NULL
<	NULL
.	NULL

<	NULL
e	NULL
]	NULL
(	NULL
ap	NULL
)	NULL
D	NULL
3	NULL
Reporter	NULL
Cell	NULL
Lines	NULL
a	NULL
a	NULL
a	NULL
The	NULL
family	NULL
keeps	NULL
growing	NULL
Learn	NULL
more	NULL
Rs	NULL
teJournal	NULL
o	NULL
Differential	NULL
Regulation	NULL
of	NULL
4E-BPI1	NULL
and	NULL
ﬁé	NULL
‘	NULL
flmmunolo	NULL
gy	NULL
4E-BP2	NULL
,	NULL
Two	NULL
Repressors	NULL
of	NULL
Translation	NULL
Initiation	NULL
,	NULL
During	NULL
Human	NULL
Myeloid	NULL
Cell	NULL
Differentiation	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Annabelle	NULL
Grolleau	NULL
,	NULL
Nahum	NULL
Sonenberg	NULL
,	NULL
Juana	NULL
Wietzerbin	NULL
and	NULL
Laura	NULL
Beretta	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:3491-3497	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/6/3491	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
24	NULL
articles	NULL
,	NULL
10	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/6/3491	NULL
full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Differential	NULL
Regulation	NULL
of	NULL
4E-BPI1	NULL
and	NULL
4E-BP2	NULL
,	NULL
Two	NULL
Repressors	NULL
of	NULL
Translation	NULL
Initiation	NULL
,	NULL
During	NULL
Human	NULL
Myeloid	NULL
Cell	NULL
Differentiation	NULL
Annabelle	NULL
Grolleau	NULL
,	NULL
*	NULL
Nahum	NULL
Sonenberg	NULL
,	NULL
``	NULL
Juana	NULL
Wietzerbin	NULL
,	NULL
*	NULL
and	NULL
Laura	NULL
Beretta'*	NULL
Human	NULL
myeloid	NULL
differentiation	NULL
is	NULL
accompanied	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
cell	NULL
proliferation	NULL
.	NULL

Because	NULL
the	NULL
translation	NULL
rate	NULL
is	NULL
an	NULL
important	NULL
determinant	NULL
of	NULL
cell	NULL
proliferation	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
translation	NULL
initiation	NULL
during	NULL
human	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
using	NULL
the	NULL
HL-60	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
U-937	NULL
monoblastic	NULL
cell	NULL
line	NULL
.	NULL

A	NULL
decrease	NULL
in	NULL
the	NULL
translation	NULL
rate	NULL
is	NULL
observed	NULL
when	NULL
the	NULL
cells	NULL
are	NULL
induced	NULL
to	NULL
differentiate	NULL
along	NULL
the	NULL
monocytic/macrophage	NULL
pathway	NULL
or	NULL
along	NULL
the	NULL
granulocytic	NULL
pathway	NULL
.	NULL

The	NULL
inhibition	NULL
in	NULL
protein	NULL
synthesis	NULL
correlates	NULL
with	NULL
specific	NULL
regulation	NULL
of	NULL
two	NULL
repressors	NULL
of	NULL
translation	NULL
initiation	NULL
,	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
.	NULL

Induction	NULL
of	NULL
HL-60	NULL
and	NULL
U-937	NULL
cell	NULL
differentiation	NULL
into	NULL
monocytes/macrophages	NULL
by	NULL
IFN-y	NULL
or	NULL
PMA	NULL
results	NULL
in	NULL
a	NULL
dephosphorylation	NULL
and	NULL
consequent	NULL
activation	NULL
of	NULL
4E-BP1	NULL
.	NULL

Dephosphorylation	NULL
of	NULL
4E-BP1	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
U-937	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
into	NULL
monocytes/macrophages	NULL
following	NULL
treatment	NULL
with	NULL
retinoic	NULL
acid	NULL
or	NULL
DMSO	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
HL-60	NULL
cells	NULL
with	NULL
retinoic	NULL
acid	NULL
or	NULL
DMSO	NULL
,	NULL
which	NULL
results	NULL
in	NULL
a	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
,	NULL
decreases	NULL
4E-BP1	NULL
amount	NULL
without	NULL
affecting	NULL
its	NULL
phosphorylation	NULL
and	NULL
strongly	NULL
increases	NULL
4E-BP2	NULL
amount	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
provide	NULL
evidence	NULL
for	NULL
differential	NULL
regulation	NULL
of	NULL
the	NULL
translational	NULL
machinery	NULL
during	NULL
human	NULL
myeloid	NULL
differentiation	NULL
,	NULL
specific	NULL
to	NULL
the	NULL
monocytic/macrophage	NULL
pathway	NULL
or	NULL
to	NULL
the	NULL
granulocytic	NULL
pathway	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
3491-3497.	NULL
uring	NULL
the	NULL
process	NULL
of	NULL
myeloid	NULL
differentiation	NULL
,	NULL
pluripotent	NULL
hemopoietic	NULL
stem	NULL
cells	NULL
become	NULL
committed	NULL
to	NULL
myeloid	NULL
precursor	NULL
cells	NULL
and	NULL
eventually	NULL
differentiate	NULL
into	NULL
func-tional	NULL
,	NULL
morphologically	NULL
distinct	NULL
end-stage	NULL
myeloid	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

This	NULL
event	NULL
proceeds	NULL
through	NULL
coordinate	NULL
expression	NULL
of	NULL
numerous	NULL
genes	NULL
.	NULL

The	NULL
development	NULL
of	NULL
terminally	NULL
differentiated	NULL
,	NULL
nondividing	NULL
,	NULL
mature	NULL
granulocytes	NULL
and	NULL
macrophages	NULL
is	NULL
accompanied	NULL
by	NULL
the	NULL
loss	NULL
of	NULL
the	NULL
proliferation	NULL
potential	NULL
of	NULL
the	NULL
precursor	NULL
cells	NULL
.	NULL

The	NULL
translation	NULL
rate	NULL
in	NULL
an	NULL
important	NULL
determinant	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
,	NULL
and	NULL
generally	NULL
varies	NULL
in	NULL
response	NULL
to	NULL
treatment	NULL
with	NULL
growth	NULL
factors	NULL
,	NULL
cytokines	NULL
,	NULL
hormones	NULL
,	NULL
and	NULL
mitogens	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
control	NULL
of	NULL
translation	NULL
occurs	NULL
at	NULL
the	NULL
level	NULL
of	NULL
initiation	NULL
.	NULL

Translation	NULL
initiation	NULL
entails	NULL
the	NULL
process	NULL
leading	NULL
to	NULL
the	NULL
positioning	NULL
of	NULL
the	NULL
ribosome	NULL
at	NULL
the	NULL
AUG	NULL
initiation	NULL
codon	NULL
.	NULL

Cellular	NULL
mRNAs	NULL
contain	NULL
a	NULL
cap	NULL
structure	NULL
(	NULL
m7G	NULL
(	NULL
5	NULL
'	NULL
)	NULL
ppp	NULL
(	NULL
5	NULL
)	NULL
N	NULL
,	NULL
in	NULL
which	NULL
N	NULL
is	NULL
any	NULL
nucleotide	NULL
)	NULL
at	NULL
their	NULL
5	NULL
'	NULL
termini	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
multisubunit	NULL
translation	NULL
initiation	NULL
factor	NULL
eIF4F	NULL
binds	NULL
to	NULL
the	NULL
cap	NULL
structure	NULL
via	NULL
the	NULL
eIF4E	NULL
subunit	NULL
to	NULL
promote	NULL
ribosome	NULL
binding	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Two	NULL
repressors	NULL
of	NULL
cap-mediated	NULL
translation	NULL
,	NULL
termed	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
(	NULL
eIF4E-binding	NULL
proteins-l	NULL
and	NULL
-2	NULL
)	NULL
,	NULL
also	NULL
known	NULL
as	NULL
PHAS	NULL
,	NULL
have	NULL
been	NULL
characterized	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

4E-BP1	NULL
and	NULL
4E-BP2	NULL
are	NULL
heat-	NULL
and	NULL
acid-stable	NULL
proteins	NULL
whose	NULL
activity	NULL
is	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
(	NULL
5-8	NULL
)	NULL
.	NULL

Dephosphorylated	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
interact	NULL
with	NULL
eIF4E	NULL
,	NULL
and	NULL
these	NULL
interactions	NULL
result	NULL
in	NULL
the	NULL
specific	NULL
inhibition	NULL
of	NULL
cap-dependent	NULL
translation	NULL
,	NULL
both	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
5	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
overexpression	NULL
of	NULL
4E-BPs	NULL
reduces	NULL
cell	NULL
prolif-	NULL
*Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
U.365	NULL
,	NULL
Institut	NULL
Curie	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
McGill	NULL
Cancer	NULL
Center	NULL
,	NULL
McGill	NULL
University	NULL
,	NULL
Montreal	NULL
,	NULL
Canada	NULL
Received	NULL
for	NULL
publication	NULL
July	NULL
22	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
December	NULL
18	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Laura	NULL
Beretta	NULL
,	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
U.365	NULL
,	NULL
Institut	NULL
Curie	NULL
,	NULL
26	NULL
rue	NULL
d	NULL
'	NULL
UIm	NULL
,	NULL
75005	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
Iberetta	NULL
@	NULL
curie.fr	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
eration	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
recently	NULL
reported	NULL
that	NULL
expression	NULL
of	NULL
4E-BP2	NULL
is	NULL
down-regulated	NULL
during	NULL
human	NULL
thymocyte	NULL
maturation	NULL
,	NULL
and	NULL
that	NULL
may	NULL
be	NULL
a	NULL
determinant	NULL
in	NULL
their	NULL
different	NULL
proliferation	NULL
potential	NULL
during	NULL
maturation	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Our	NULL
goal	NULL
was	NULL
to	NULL
investigate	NULL
translation	NULL
rates	NULL
of	NULL
4E-BPs	NULL
function	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
cells	NULL
.	NULL

Many	NULL
of	NULL
the	NULL
myeloid	NULL
cell	NULL
lines	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
terminally	NULL
differentiate	NULL
along	NULL
one	NULL
or	NULL
several	NULL
pathways	NULL
to	NULL
mature	NULL
into	NULL
differentiated	NULL
cells	NULL
,	NULL
and	NULL
therefore	NULL
,	NULL
they	NULL
provide	NULL
a	NULL
useful	NULL
experimental	NULL
model	NULL
to	NULL
study	NULL
the	NULL
expression	NULL
of	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
during	NULL
monocytopoiesis	NULL
and	NULL
gran-ulopoiesis	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
HL-60	NULL
cell	NULL
line	NULL
has	NULL
been	NULL
of	NULL
interest	NULL
because	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
undergo	NULL
both	NULL
granulocytic	NULL
maturation	NULL
and	NULL
monocyte/macrophage	NULL
differentiation	NULL
following	NULL
exposure	NULL
to	NULL
various	NULL
agents	NULL
.	NULL

The	NULL
monoblastic	NULL
U-937	NULL
cells	NULL
have	NULL
a	NULL
clear	NULL
monocytic	NULL
lineage	NULL
derivation	NULL
and	NULL
are	NULL
a	NULL
widely	NULL
used	NULL
model	NULL
for	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Chemicals	NULL
and	NULL
reagents	NULL
Human	NULL
IFN-y	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Roussel-Uclaf	NULL
(	NULL
Romainville	NULL
,	NULL
France	NULL
)	NULL
,	NULL
PMA	NULL
was	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Quentin-Fallavier	NULL
,	NULL
France	NULL
)	NULL
,	NULL
all-trans	NULL
RA	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Hoffman-La	NULL
Roche	NULL
(	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
,	NULL
and	NULL
DMSO	NULL
was	NULL
from	NULL
Merck	NULL
(	NULL
Nogent	NULL
sur	NULL
Marne	NULL
,	NULL
France	NULL
)	NULL
.	NULL

PMA	NULL
and	NULL
RA	NULL
were	NULL
dissolved	NULL
in	NULL
absolute	NULL
ethanol	NULL
at	NULL
an	NULL
initial	NULL
concentration	NULL
of	NULL
1	NULL
mg/ml	NULL
and	NULL
10~	NULL
M	NULL
,	NULL
respec-tively	NULL
.	NULL

Dilutions	NULL
were	NULL
performed	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
.	NULL

The	NULL
final	NULL
concentration	NULL
of	NULL
ethanol	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

Cell	NULL
and	NULL
culture	NULL
conditions	NULL
The	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
HL-60	NULL
and	NULL
U-937	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Sarl	NULL
,	NULL
France	NULL
)	NULL
,	NULL
using	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
buffer	NULL
,	NULL
and	NULL
gentamicin	NULL
(	NULL
20	NULL
pg/ml	NULL
)	NULL
.	NULL

The	NULL
cultures	NULL
were	NULL
incubated	NULL
in	NULL
humidified	NULL
air	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
at	NULL
37°C	NULL
and	NULL
subcultivated	NULL
twice	NULL
per	NULL
week	NULL
.	NULL

Abbreviation	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
RA	NULL
,	NULL
retinoic	NULL
acid	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3492	NULL
Induction	NULL
of	NULL
differentiation	NULL
Twelve	NULL
to	NULL
fifteen	NULL
hours	NULL
before	NULL
induction	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
resus-pended	NULL
in	NULL
fresh	NULL
medium	NULL
.	NULL

HL-60	NULL
cells	NULL
and	NULL
U-937	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
for	NULL
1	NULL
to	NULL
5	NULL
days	NULL
,	NULL
by	NULL
treatment	NULL
with	NULL
5	NULL
ng/ml	NULL
PMA	NULL
,	NULL
200	NULL
U/ml	NULL
IFN-y	NULL
,	NULL
1	NULL
M	NULL
all-trans	NULL
RA	NULL
,	NULL
or	NULL
1	NULL
%	NULL
DMSO	NULL
,	NULL
without	NULL
any	NULL
change	NULL
of	NULL
media	NULL
.	NULL

Differentiation	NULL
was	NULL
monitored	NULL
after	NULL
3	NULL
and	NULL
5	NULL
days	NULL
by	NULL
determining	NULL
cell	NULL
growth	NULL
with	NULL
a	NULL
Coulter	NULL
(	NULL
Margency	NULL
,	NULL
France	NULL
)	NULL
counter	NULL
ZM	NULL
equipped	NULL
with	NULL
a	NULL
Coultronic	NULL
256	NULL
channelizer	NULL
,	NULL
and	NULL
viability	NULL
was	NULL
estimated	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
.	NULL

Cell	NULL
morphology	NULL
was	NULL
examined	NULL
by	NULL
staining	NULL
of	NULL
cytocentrifuged	NULL
cells	NULL
with	NULL
May-Griinwald	NULL
and	NULL
subsequent	NULL
light-micro-scope	NULL
examination	NULL
.	NULL

Cell	NULL
surface	NULL
Ag	NULL
analysis	NULL
The	NULL
appearance	NULL
of	NULL
various	NULL
cellular	NULL
markers	NULL
normally	NULL
associated	NULL
with	NULL
the	NULL
maturation	NULL
of	NULL
the	NULL
granulocytic	NULL
and	NULL
monocytic	NULL
elements	NULL
was	NULL
also	NULL
deter-mined	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
cell	NULL
surface	NULL
Ag	NULL
expression	NULL
was	NULL
performed	NULL
by	NULL
direct	NULL
immunofluorescence	NULL
using	NULL
flow	NULL
cytometry	NULL
(	NULL
FACScan	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
control	NULL
and	NULL
induced	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
1	NULL
pg/ml	NULL
monoclonal	NULL
mouse	NULL
anti-human	NULL
FITC-conjugated	NULL
anti-CD11b	NULL
(	NULL
Mac-1	NULL
;	NULL
BEAR	NULL
1	NULL
;	NULL
mIgG1	NULL
;	NULL
Immunotech	NULL
,	NULL
Luminy	NULL
,	NULL
France	NULL
)	NULL
and	NULL
with	NULL
0.5	NULL
ug/ml	NULL
monoclonal	NULL
mouse	NULL
anti-human	NULL
FITC-conjugated	NULL
anti-HLA-DR	NULL
(	NULL
B8.12.2	NULL
,	NULL
mIgG2b	NULL
;	NULL
Im-munotech	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
BSA	NULL
,	NULL
0,1	NULL
%	NULL
sodium	NULL
azide	NULL
,	NULL
fixed	NULL
in	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
and	NULL
analyzed	NULL
for	NULL
fluorescence	NULL
.	NULL

Data	NULL
analysis	NULL
was	NULL
based	NULL
on	NULL
examination	NULL
of	NULL
5000	NULL
cells/sample	NULL
.	NULL

The	NULL
results	NULL
are	NULL
given	NULL
as	NULL
percent	NULL
positive	NULL
cells	NULL
,	NULL
and	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
was	NULL
obtained	NULL
by	NULL
subtracting	NULL
the	NULL
peak	NULL
channel	NULL
number	NULL
of	NULL
the	NULL
negative	NULL
control	NULL
from	NULL
the	NULL
peak	NULL
channel	NULL
number	NULL
of	NULL
the	NULL
corresponding	NULL
experimental	NULL
sample	NULL
.	NULL

SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
Cells	NULL
were	NULL
rinsed	NULL
twice	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
lysed	NULL
by	NULL
successive	NULL
freeze-thaw	NULL
cycles	NULL
,	NULL
in	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
buffer	NULL
containing	NULL
5	NULL
mM	NULL
EDTA	NULL
and	NULL
100	NULL
mM	NULL
KCI	NULL
.	NULL

The	NULL
homogenate	NULL
was	NULL
centrifugated	NULL
at	NULL
6000	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
collected	NULL
.	NULL

To	NULL
analyze	NULL
for	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
was	NULL
dissolved	NULL
in	NULL
Laeminli	NULL
sample	NULL
buffer	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
15	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
onto	NULL
a	NULL
0.22-um	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Dassel	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
which	NULL
was	NULL
blocked	NULL
in	NULL
5	NULL
%	NULL
milk	NULL
for	NULL
2	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
for	NULL
2	NULL
h	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
against	NULL
4E-BP1	NULL
(	NULL
11208	NULL
)	NULL
and	NULL
4E-BP2	NULL
(	NULL
11211	NULL
)	NULL
in	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
]	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
buffer	NULL
containing	NULL
150	NULL
mM	NULL
NaCl	NULL
at	NULL
a	NULL
dilution	NULL
1/1000	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
then	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
horseradish	NULL
peroxidase-labeled	NULL
conjugate	NULL
Ab	NULL
at	NULL
a	NULL
dilution	NULL
1/2000	NULL
.	NULL

Immunodetection	NULL
was	NULL
realized	NULL
by	NULL
enhanced	NULL
chemoluminescence	NULL
(	NULL
ECL	NULL
)	NULL
reagents	NULL
and	NULL
autoradiography	NULL
.	NULL

RNA	NULL
extraction	NULL
and	NULL
Northern	NULL
blot	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
by	NULL
guanidium	NULL
isothiocyanate	NULL
lysis	NULL
and	NULL
CsCl	NULL
cen-trifugation	NULL
(	NULL
13	NULL
)	NULL
and	NULL
separated	NULL
by	NULL
electrophoresis	NULL
through	NULL
1	NULL
%	NULL
agarose	NULL
,	NULL
6	NULL
%	NULL
formaldehyde	NULL
gels	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
denaturated	NULL
total	NULL
RNA	NULL
were	NULL
used	NULL
for	NULL
each	NULL
lane	NULL
.	NULL

After	NULL
transfer	NULL
onto	NULL
nylon	NULL
membrane	NULL
,	NULL
RNA	NULL
blots	NULL
were	NULL
UV	NULL
cross-linked	NULL
(	NULL
UV	NULL
Stratalinker	NULL
,	NULL
120,000	NULL
uJ	NULL
;	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
CA	NULL
)	NULL
,	NULL
prehybridized	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5X	NULL
SSPE	NULL
,	NULL
1X	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
SDS	NULL
for	NULL
24	NULL
h	NULL
at	NULL
42°C	NULL
,	NULL
and	NULL
then	NULL
hybridized	NULL
for	NULL
24	NULL
h	NULL
at	NULL
42°C	NULL
in	NULL
the	NULL
same	NULL
solution	NULL
containing	NULL
200	NULL
pg/ml	NULL
of	NULL
heat-denatured	NULL
salmon	NULL
sperm	NULL
DNA	NULL
and	NULL
P-labeled	NULL
cDNA	NULL
probe	NULL
(	NULL
adding	NULL
approximatively	NULL
2	NULL
X	NULL
10°	NULL
cpm	NULL
of	NULL
the	NULL
labeled	NULL
probe/m	NULL
!	NULL

1	NULL
)	NULL
.	NULL

Following	NULL
washes	NULL
of	NULL
increase	NULL
stringency	NULL
,	NULL
membranes	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
autoradiographed	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
rehybridized	NULL
with	NULL
an	NULL
actin	NULL
probe	NULL
to	NULL
ensure	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
present	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

Probes	NULL
The	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
probes	NULL
were	NULL
a	NULL
0.8-kb	NULL
human	NULL
4E-BP1	NULL
and	NULL
a	NULL
3.5-kb	NULL
human	NULL
4E-BP2	NULL
cDNA	NULL
fragment	NULL
.	NULL

The	NULL
control	NULL
probe	NULL
was	NULL
an	NULL
actin	NULL
probe	NULL
made	NULL
of	NULL
a	NULL
2.1-kb	NULL
human	NULL
cDNA	NULL
fragment	NULL
.	NULL

For	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
cDNA	NULL
inserts	NULL
were	NULL
purified	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
°°PJATP	NULL
using	NULL
a	NULL
random	NULL
primer	NULL
kit	NULL
(	NULL
Multiprime	NULL
labeling	NULL
kit	NULL
;	NULL
Amersham	NULL
,	NULL
Orsay	NULL
,	NULL
France	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacter	NULL
's	NULL
instructions	NULL
.	NULL

Metabolic	NULL
labeling	NULL
Undifferentiated	NULL
and	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
in	NULL
methionine-free	NULL
RPMI	NULL
1640	NULL
medium	NULL
.	NULL

[	NULL
*°S	NULL
]	NULL
Methionine	NULL
(	NULL
100	NULL
uCi	NULL
)	NULL
was	NULL
added	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
buffer	NULL
containing	NULL
5	NULL
mM	NULL
EDTA	NULL
and	NULL
100	NULL
mM	NULL
KCI	NULL
.	NULL

The	NULL
radioactivity	NULL
incorporated	NULL
into	NULL
TCA-precipitable	NULL
material	NULL
was	NULL
measured	NULL
.	NULL

REPRESSORS	NULL
OF	NULL
TRANSLATION	NULL
AND	NULL
MYELOID	NULL
DIFFERENTIATION	NULL
Results	NULL
Assessment	NULL
of	NULL
HL-60	NULL
cell	NULL
differentiation	NULL
Differentiation	NULL
of	NULL
the	NULL
promyelocytic	NULL
HL-60	NULL
cells	NULL
into	NULL
monocytes/macrophages	NULL
or	NULL
into	NULL
granulocytes	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
vitro	NULL
by	NULL
treating	NULL
the	NULL
cells	NULL
with	NULL
different	NULL
agents	NULL
,	NULL
including	NULL
IFN-y	NULL
or	NULL
PMA	NULL
for	NULL
monocytes/macrophages	NULL
and	NULL
RA	NULL
or	NULL
DMSO	NULL
for	NULL
granulocytes	NULL
(	NULL
14	NULL
)	NULL
.	NULL

We	NULL
treated	NULL
HL-60	NULL
cells	NULL
with	NULL
IFN-y	NULL
,	NULL
PMA	NULL
,	NULL
RA	NULL
,	NULL
or	NULL
DMSO	NULL
for	NULL
3	NULL
and	NULL
5	NULL
days	NULL
and	NULL
determined	NULL
their	NULL
differentiation	NULL
stage	NULL
by	NULL
three	NULL
criteria	NULL
:	NULL
cell	NULL
proliferation	NULL
,	NULL
morphology	NULL
,	NULL
and	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
specific	NULL
markers	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
an	NULL
initial	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°/ml	NULL
and	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
,	NULL
RA	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
,	NULL
or	NULL
DMSO	NULL
(	NULL
1	NULL
%	NULL
)	NULL
.	NULL

Following	NULL
treatment	NULL
with	NULL
each	NULL
agent	NULL
,	NULL
cell	NULL
proliferation	NULL
was	NULL
strongly	NULL
reduced	NULL
at	NULL
3	NULL
and	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

The	NULL
PMA-treated	NULL
cells	NULL
ceased	NULL
to	NULL
proliferate	NULL
after	NULL
3	NULL
days	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
more	NULL
than	NULL
80	NULL
%	NULL
viable	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
culture	NULL
period	NULL
,	NULL
except	NULL
for	NULL
the	NULL
PMA-treated	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
cell	NULL
viability	NULL
at	NULL
5	NULL
days	NULL
was	NULL
about	NULL
65	NULL
%	NULL
.	NULL

Morphology	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
analyzed	NULL
by	NULL
the	NULL
method	NULL
of	NULL
May-Griinwald	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
untreated	NULL
cells	NULL
,	NULL
cultured	NULL
HL-60	NULL
cells	NULL
are	NULL
predominantly	NULL
promy-elocytes	NULL
with	NULL
characteristic	NULL
cytoplasmic	NULL
granules	NULL
,	NULL
large	NULL
nuclei	NULL
,	NULL
and	NULL
prominent	NULL
nucleoli	NULL
.	NULL

HL-60	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
IFN-y	NULL
or	NULL
PMA	NULL
for	NULL
3	NULL
days	NULL
acquired	NULL
monocyte/macrophage	NULL
morphology	NULL
,	NULL
with	NULL
a	NULL
high	NULL
nuclear/cytoplasmic	NULL
ratio	NULL
,	NULL
vacuolization	NULL
,	NULL
and	NULL
blebbing	NULL
,	NULL
whereas	NULL
HL-60	NULL
cells	NULL
treated	NULL
with	NULL
RA	NULL
or	NULL
DMSO	NULL
for	NULL
3	NULL
days	NULL
acquired	NULL
granulocyte	NULL
morphology	NULL
,	NULL
with	NULL
chromatin	NULL
conden-sation	NULL
,	NULL
loss	NULL
of	NULL
nucleoli	NULL
,	NULL
and	NULL
nuclear	NULL
lobulation	NULL
.	NULL

The	NULL
PMA-treated	NULL
cells	NULL
became	NULL
adherent	NULL
to	NULL
the	NULL
substrate	NULL
,	NULL
with	NULL
almost	NULL
100	NULL
%	NULL
cell	NULL
attachment	NULL
observed	NULL
by	NULL
48	NULL
h.	NULL
Similar	NULL
morphologies	NULL
were	NULL
observed	NULL
after	NULL
5	NULL
days	NULL
of	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
also	NULL
determined	NULL
by	NULL
FACScan	NULL
analysis	NULL
of	NULL
specific	NULL
markers	NULL
,	NULL
CD11b	NULL
and	NULL
HLA-DR	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
CD11b	NULL
surface	NULL
Ag	NULL
is	NULL
restricted	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
myelomonocytic	NULL
lineage	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
is	NULL
up-regulated	NULL
during	NULL
granulocytic	NULL
and	NULL
monocytic	NULL
differentiation	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
MHC	NULL
class	NULL
II	NULL
determinant	NULL
,	NULL
HLA-DR	NULL
,	NULL
is	NULL
expressed	NULL
transiently	NULL
during	NULL
early	NULL
development	NULL
of	NULL
myelomonocytic	NULL
precursors	NULL
and	NULL
later	NULL
in	NULL
monocytes	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
stimuli	NULL
,	NULL
HL-60	NULL
cells	NULL
express	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
two	NULL
Ags	NULL
.	NULL

Exposure	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
the	NULL
four	NULL
inducers	NULL
(	NULL
IFN-y	NULL
,	NULL
PMA	NULL
,	NULL
RA	NULL
,	NULL
and	NULL
DMSO	NULL
)	NULL
for	NULL
3	NULL
days	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
of	NULL
CD11b	NULL
surface	NULL
Ag	NULL
expression	NULL
.	NULL

Upon	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
by	NULL
IFN-y	NULL
or	NULL
PMA	NULL
treatment	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
HLA-DR	NULL
was	NULL
increased	NULL
signif-icantly	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
HLA-DR	NULL
determinant	NULL
was	NULL
not	NULL
induced	NULL
upon	NULL
treatment	NULL
with	NULL
RA	NULL
or	NULL
DMSO	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
into	NULL
granulocytes	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Protein	NULL
synthesis	NULL
rates	NULL
in	NULL
undifferentiated	NULL
and	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
As	NULL
protein	NULL
synthesis	NULL
rate	NULL
is	NULL
a	NULL
major	NULL
determinant	NULL
of	NULL
cell	NULL
proliferation	NULL
,	NULL
we	NULL
analyzed	NULL
protein	NULL
synthesis	NULL
rates	NULL
during	NULL
differentiation	NULL
of	NULL
the	NULL
HL-60	NULL
cells	NULL
.	NULL

The	NULL
translation	NULL
rate	NULL
was	NULL
determined	NULL
by	NULL
metabolic	NULL
labeling	NULL
of	NULL
cells	NULL
with	NULL
[	NULL
°°S	NULL
)	NULL
Jmethionine	NULL
,	NULL
and	NULL
incorporation	NULL
rates	NULL
were	NULL
measured	NULL
3	NULL
and	NULL
5	NULL
days	NULL
after	NULL
stimulation	NULL
.	NULL

Protein	NULL
synthesis	NULL
was	NULL
strongly	NULL
inhibited	NULL
in	NULL
HL-60	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
into	NULL
monocytes/macrophages	NULL
after	NULL
IFN-y	NULL
and	NULL
PMA	NULL
treatments	NULL
for	NULL
5	NULL
days	NULL
(	NULL
75	NULL
and	NULL
90	NULL
%	NULL
inhibition	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Slight	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
was	NULL
observed	NULL
with	NULL
IFN-y	NULL
after	NULL
3	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
whereas	NULL
maximal	NULL
inhibition	NULL
was	NULL
already	NULL
obtained	NULL
after	NULL
3	NULL
days	NULL
of	NULL
treatment	NULL
with	NULL
PMA	NULL
.	NULL

A	NULL
similar	NULL
strong	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
into	NULL
granulocytes	NULL
in	NULL
response	NULL
to	NULL
RA	NULL
or	NULL
DMSO	NULL
for	NULL
5	NULL
days	NULL
(	NULL
85	NULL
%	NULL
inhibition	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
reduction	NULL
of	NULL
protein	NULL
synthesis	NULL
is	NULL
a	NULL
general	NULL
mechanism	NULL
,	NULL
common	NULL
to	NULL
the	NULL
two	NULL
pathways	NULL
of	NULL
HL-60	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
130	NULL
``	NULL
E	NULL
wo	NULL
201	NULL
0	NULL
X	NULL
©	NULL
a	NULL
E	NULL
2	NULL
2	NULL
404	NULL
C	NULL
o	NULL
3493	NULL
-	NULL
#	NULL
-	NULL
Control	NULL
-A-	NULL
IFN-y	NULL
-e-	NULL
RA	NULL
-o-	NULL
_	NULL
DMSO	NULL
-i-	NULL
_	NULL
PMA	NULL
FIGURE	NULL
1	NULL
.	NULL

Assessment	NULL
of	NULL
HL-60	NULL
differentiation	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
an	NULL
initial	NULL
density	NULL
of	NULL
2	NULL
%	NULL
10°	NULL
cells/ml	NULL
without	NULL
or	NULL
with	NULL
200	NULL
U/ml	NULL
IFN-y	NULL
,	NULL
5	NULL
ng/ml	NULL
PMA	NULL
,	NULL
1	NULL
uM	NULL
RA	NULL
,	NULL
or	NULL
1	NULL
%	NULL
DMSO	NULL
,	NULL
and	NULL
were	NULL
cultured	NULL
for	NULL
5	NULL
days	NULL
without	NULL
any	NULL
change	NULL
of	NULL
media	NULL
.	NULL

A	NULL
,	NULL
Cell	NULL
growth	NULL
curves	NULL
of	NULL
untreated	NULL
and	NULL
treated	NULL
HL-60	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
counted	NULL
after	NULL
3	NULL
and	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
.	NULL

The	NULL
shown	NULL
concentrations	NULL
are	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
,	NULL
and	NULL
the	NULL
error	NULL
bars	NULL
indicate	NULL
the	NULL
SD	NULL
from	NULL
the	NULL
mean	NULL
.	NULL

B	NULL
,	NULL
Morphology	NULL
of	NULL
uninduced	NULL
and	NULL
induced	NULL
HL-60	NULL
cells	NULL
.	NULL

Photomicrographs	NULL
of	NULL
May-Griinwald	NULL
stained	NULL
cytospin	NULL
preparations	NULL
are	NULL
recorded	NULL
from	NULL
the	NULL
following	NULL
sources	NULL
:	NULL
HL-60	NULL
cells	NULL
treated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
control	NULL
medium	NULL
(	NULL
a	NULL
)	NULL
;	NULL
with	NULL
IFN-y	NULL
(	NULL
b	NULL
)	NULL
;	NULL
with	NULL
PMA	NULL
(	NULL
c	NULL
)	NULL
;	NULL
with	NULL
RA	NULL
(	NULL
d	NULL
)	NULL
;	NULL
or	NULL
withDMSO	NULL
(	NULL
e	NULL
)	NULL
.	NULL

»	NULL
F	NULL
«	NULL
Wmata	NULL
cell	NULL
differentiation	NULL
.	NULL

It	NULL
correlates	NULL
well	NULL
with	NULL
the	NULL
proliferation	NULL
status	NULL
of	NULL
these	NULL
cells	NULL
during	NULL
their	NULL
differentiation	NULL
,	NULL
with	NULL
a	NULL
faster	NULL
and	NULL
stonger	NULL
effect	NULL
of	NULL
PMA	NULL
treatment	NULL
as	NULL
compared	NULL
with	NULL
IFN-y	NULL
,	NULL
RA	NULL
,	NULL
or	NULL
DMSO	NULL
treatments	NULL
.	NULL

Expression	NULL
of	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
during	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
along	NULL
the	NULL
monocytic/macrophage	NULL
pathway	NULL
To	NULL
study	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
IFN-y	NULL
and	NULL
PMA	NULL
inhibit	NULL
protein	NULL
synthesis	NULL
and	NULL
induce	NULL
monocytic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
these	NULL
agents	NULL
on	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
expression	NULL
was	NULL
ex-amined	NULL
.	NULL

Three	NULL
isoforms	NULL
of	NULL
4E-BP1	NULL
(	NULL
indicated	NULL
by	NULL
the	NULL
arrows	NULL
;	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
were	NULL
detected	NULL
following	NULL
immunoblotting	NULL
of	NULL
extracts	NULL
from	NULL
un-	NULL
treated	NULL
HL-60	NULL
cells	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
these	NULL
isoforms	NULL
represent	NULL
various	NULL
phosphorylation	NULL
states	NULL
of	NULL
4E-BP1	NULL
,	NULL
the	NULL
fastest	NULL
migrating	NULL
electrophoretic	NULL
isoform	NULL
corresponding	NULL
to	NULL
the	NULL
unphosphor-ylated	NULL
4E-BP1	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Both	NULL
IFN-y	NULL
and	NULL
PMA	NULL
induced	NULL
a	NULL
dephosphorylation	NULL
of	NULL
4E-BP1	NULL
.	NULL

Whereas	NULL
slight	NULL
dephosphorylation	NULL
of	NULL
4E-BPI	NULL
was	NULL
observed	NULL
after	NULL
3	NULL
days	NULL
of	NULL
IFN-y	NULL
or	NULL
PMA	NULL
treatments	NULL
,	NULL
complete	NULL
dephosphorylation	NULL
was	NULL
obtained	NULL
after	NULL
5	NULL
days	NULL
.	NULL

No	NULL
significant	NULL
modification	NULL
was	NULL
observed	NULL
in	NULL
46-BP2	NULL
expression	NULL
during	NULL
the	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
by	NULL
both	NULL
inducers	NULL
.	NULL

Thus	NULL
,	NULL
during	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
into	NULL
monocytes/mac-rophages	NULL
,	NULL
dephosphorylation	NULL
of	NULL
4E-BP1	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
observed	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3494	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Surface	NULL
marker	NULL
expression	NULL
on	NULL
untreated	NULL
and	NULL
treated	NULL
HL-60	NULL
cells	NULL
``	NULL
%	NULL
Positive	NULL
Cells	NULL
(	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
)	NULL
Treatment	NULL
CD11b	NULL
HLA-DR	NULL
None	NULL
11	NULL
(	NULL
1	NULL
)	NULL
8	NULL
(	NULL
1	NULL
)	NULL
IFN-y	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
60	NULL
(	NULL
40	NULL
)	NULL
46	NULL
(	NULL
38	NULL
)	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
51	NULL
(	NULL
65	NULL
)	NULL
22	NULL
(	NULL
34	NULL
)	NULL
RA	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
40	NULL
(	NULL
10	NULL
)	NULL
9	NULL
(	NULL
1	NULL
)	NULL
DMSO	NULL
(	NULL
1	NULL
%	NULL
)	NULL
37	NULL
(	NULL
5	NULL
)	NULL
2	NULL
(	NULL
5	NULL
)	NULL
``	NULL
Cells	NULL
were	NULL
treated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
indicated	NULL
agents	NULL
and	NULL
assayed	NULL
by	NULL
flow	NULL
cytometry	NULL
for	NULL
MAC-1/CD11b	NULL
and	NULL
HLA-DR	NULL
cell	NULL
surface	NULL
expression	NULL
(	NULL
%	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Mean	NULL
fluorescence	NULL
intensity	NULL
is	NULL
shown	NULL
in	NULL
parentheses	NULL
.	NULL

4E-BPI1	NULL
and	NULL
4E-BP2	NULL
expression	NULL
during	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
along	NULL
the	NULL
granulocytic	NULL
pathway	NULL
To	NULL
study	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
RA	NULL
and	NULL
DMSO	NULL
inhibit	NULL
protein	NULL
synthesis	NULL
as	NULL
they	NULL
trigger	NULL
another	NULL
differentiation	NULL
pathway	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
these	NULL
agents	NULL
on	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
expression	NULL
was	NULL
also	NULL
ex-amined	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
dephosphorylation	NULL
of	NULL
46-BP1	NULL
observed	NULL
A	NULL
1004	NULL
&	NULL
Control	NULL
IFN-y	NULL
PMA	NULL
[	NULL
S	NULL
]	NULL
methionine	NULL
incorporation	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
Days	NULL
of	NULL
culture	NULL
us	NULL
)	NULL
100	NULL
4	NULL
[	NULL
S	NULL
]	NULL
methionine	NULL
incorporation	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
C	NULL
3	NULL
5	NULL
Days	NULL
of	NULL
culture	NULL
FIGURE	NULL
2	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
during	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
an	NULL
initial	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
without	NULL
or	NULL
with	NULL
200	NULL
U/ml	NULL
IFN-y	NULL
or	NULL
5	NULL
ng/ml	NULL
PMA	NULL
(	NULL
4	NULL
)	NULL
,	NULL
without	NULL
or	NULL
with	NULL
1	NULL
uM	NULL
RA	NULL
or	NULL
1	NULL
%	NULL
DMSO	NULL
(	NULL
B	NULL
)	NULL
.	NULL

After	NULL
3	NULL
and	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
10°	NULL
cells	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
in	NULL
methionine-free	NULL
medium	NULL
.	NULL

[	NULL
*°S	NULL
]	NULL
Methionine	NULL
(	NULL
100	NULL
mCi	NULL
)	NULL
was	NULL
added	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
radioactivity	NULL
incorporated	NULL
into	NULL
TCA-precipitable	NULL
material	NULL
was	NULL
measured	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
the	NULL
different	NULL
agents	NULL
are	NULL
expressed	NULL
as	NULL
percentage	NULL
of	NULL
the	NULL
control	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
conducted	NULL
three	NULL
times	NULL
,	NULL
and	NULL
the	NULL
error	NULL
bars	NULL
indicate	NULL
the	NULL
SD	NULL
from	NULL
the	NULL
mean	NULL
.	NULL

REPRESSORS	NULL
OF	NULL
TRANSLATION	NULL
AND	NULL
MYELOID	NULL
DIFFERENTIATION	NULL
4E-BPI1	NULL
-	NULL
>	NULL
--	NULL
»	NULL
Whats	NULL
«	NULL
sittin	NULL
4E-BP2	NULL
|_	NULL
wen	NULL
___	NULL
®	NULL
Fuge	NULL
m	NULL
»	NULL
|	NULL
|	NULL
Actin	NULL
l	NULL
ease	NULL
emu	NULL
wees	NULL
.	NULL

comme	NULL
P	NULL
l	NULL
c	NULL
d3	NULL
0	NULL
ds	NULL
_-	NULL
d3	NULL
__	NULL
d5	NULL
IFN-y	NULL
PMA	NULL
FIGURE	NULL
3	NULL
.	NULL

Expression	NULL
of	NULL
4E-BP	NULL
proteins	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
an	NULL
initial	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
without	NULL
(	NULL
C	NULL
)	NULL
or	NULL
with	NULL
200	NULL
U/ml	NULL
of	NULL
IFN-y	NULL
or	NULL
5	NULL
ng/ml	NULL
of	NULL
PMA	NULL
.	NULL

At	NULL
3	NULL
and	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
(	NULL
d3	NULL
and	NULL
d5	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
total	NULL
protein	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
,	NULL
using	NULL
rabbit	NULL
anti-4E-BP1	NULL
(	NULL
1:1000	NULL
)	NULL
,	NULL
rabbit	NULL
anti-4E-BP2	NULL
(	NULL
1:1000	NULL
)	NULL
Abs	NULL
,	NULL
followed	NULL
by	NULL
monoclonal	NULL
anti-actin	NULL
.	NULL

during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
,	NULL
no	NULL
variation	NULL
of	NULL
4E-BP1	NULL
phosphorylation	NULL
occurred	NULL
after	NULL
exposure	NULL
to	NULL
RA	NULL
and	NULL
DMSO	NULL
for	NULL
3	NULL
and	NULL
5	NULL
days	NULL
,	NULL
but	NULL
4E-BP1	NULL
protein	NULL
expression	NULL
was	NULL
reduced	NULL
significantly	NULL
by	NULL
two-	NULL
to	NULL
threefold	NULL
after	NULL
3	NULL
days	NULL
of	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
4E-BP2	NULL
protein	NULL
expression	NULL
was	NULL
strongly	NULL
induced	NULL
(	NULL
five-	NULL
to	NULL
sixfold	NULL
)	NULL
after	NULL
3	NULL
days	NULL
of	NULL
treatment	NULL
with	NULL
both	NULL
agents	NULL
.	NULL

Because	NULL
strong	NULL
variations	NULL
of	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
protein	NULL
expression	NULL
were	NULL
already	NULL
observed	NULL
after	NULL
3	NULL
days	NULL
of	NULL
treatment	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
kinetic	NULL
of	NULL
RA	NULL
and	NULL
DMSO	NULL
treatment	NULL
from	NULL
4	NULL
h	NULL
to	NULL
3	NULL
days	NULL
.	NULL

Maximal	NULL
induction	NULL
of	NULL
4E-BP2	NULL
protein	NULL
expression	NULL
was	NULL
observed	NULL
after	NULL
2	NULL
days	NULL
of	NULL
RA	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
and	NULL
DMSO	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
treatment	NULL
.	NULL

A	NULL
decrease	NULL
in	NULL
4E-BP1	NULL
protein	NULL
expression	NULL
was	NULL
observed	NULL
after	NULL
3	NULL
days	NULL
of	NULL
treatment	NULL
with	NULL
both	NULL
agents	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
performed	NULL
Northern	NULL
blotting	NULL
analysis	NULL
to	NULL
examine	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
mRNA	NULL
expression	NULL
during	NULL
differentiation	NULL
of	NULL
the	NULL
HL-60	NULL
cells	NULL
.	NULL

4E-BP1	NULL
and	NULL
4E-BP2	NULL
mRNA	NULL
were	NULL
detectable	NULL
as	NULL
single	NULL
transcript	NULL
of	NULL
,	NULL
respectively	NULL
,	NULL
0.8	NULL
and	NULL
3.5	NULL
kb	NULL
,	NULL
as	NULL
previously	NULL
A	NULL
aceri	NULL
-+	NULL
|	NULL
am	NULL
as	NULL
aa	NULL
-	NULL
as	NULL
4E-BP2	NULL
|	NULL
_	NULL
«	NULL
=	NULL
&	NULL
_	NULL
&	NULL
am	NULL
as	NULL
|	NULL
Actin	NULL
l	NULL
sms	NULL
wumme	NULL
P	NULL
«	NULL
emm	NULL
mune	NULL
l	NULL
c	NULL
a3	NULL
d5	NULL
__	NULL
d3	NULL
a5	NULL
RA	NULL
DMSO	NULL
B	NULL
4E-BP2	NULL
e	NULL
a	NULL
»	NULL
_	NULL
as	NULL
|	NULL
Actin	NULL
|	NULL
s	NULL
we	NULL
same	NULL
«	NULL
a	NULL
ame	NULL
-	NULL
``	NULL
'|	NULL
4h	NULL
Sh	NULL
16h	NULL
di	NULL
d2	NULL
d3	NULL
FIGURE	NULL
4	NULL
.	NULL

Expression	NULL
of	NULL
4E-BP	NULL
proteins	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Total	NULL
cell	NULL
extracts	NULL
from	NULL
untreated	NULL
(	NULL
C	NULL
)	NULL
or	NULL
treated	NULL
cells	NULL
for	NULL
3	NULL
and	NULL
5	NULL
days	NULL
(	NULL
d3	NULL
and	NULL
d5	NULL
)	NULL
with	NULL
RA	NULL
(	NULL
1	NULL
M	NULL
)	NULL
or	NULL
DMSO	NULL
(	NULL
1	NULL
%	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
,	NULL
using	NULL
anti-4E-BP1	NULL
and	NULL
anti-4E-BP2	NULL
Abs	NULL
,	NULL
followed	NULL
by	NULL
monoclonal	NULL
anti-actin	NULL
.	NULL

B	NULL
,	NULL
At	NULL
various	NULL
time	NULL
periods	NULL
from	NULL
4	NULL
h	NULL
to	NULL
3	NULL
days	NULL
of	NULL
1	NULL
M	NULL
RA	NULL
treatments	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
total	NULL
protein	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
anti-4E-BP2	NULL
and	NULL
actin	NULL
Abs	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
C	NULL
-	NULL
IFN-y	NULL
RA	NULL
DMSO	NULL
4E-BP2	NULL
-	NULL
3,5	NULL
kb	NULL
4E-BP1	NULL
yee	NULL
-	NULL
0,8	NULL
kb	NULL
«	NULL
--	NULL
_	NULL
WWW	NULL
FIGURE	NULL
5	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
mRNAs	NULL
during	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

The	NULL
HL-60	NULL
were	NULL
cultured	NULL
for	NULL
3	NULL
days	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
C	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IFN-y	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
,	NULL
RA	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
,	NULL
or	NULL
DMSO	NULL
(	NULL
1	NULL
%	NULL
)	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug/lane	NULL
)	NULL
was	NULL
separated	NULL
on	NULL
formal-dehyde-agarose	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
designated	NULL
cDNA	NULL
probes	NULL
.	NULL

The	NULL
same	NULL
filter	NULL
was	NULL
subsequently	NULL
hybridized	NULL
with	NULL
the	NULL
actin	NULL
probe	NULL
to	NULL
control	NULL
the	NULL
amounts	NULL
of	NULL
RNA	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

3495	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Surface	NULL
marker	NULL
expression	NULL
of	NULL
CD11b	NULL
and	NULL
HLA-DR	NULL
on	NULL
U-937	NULL
cells	NULL
``	NULL
%	NULL
Positive	NULL
Cells	NULL
(	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
)	NULL
Treatment	NULL
CD11b	NULL
HLA-DR	NULL
None	NULL
8	NULL
(	NULL
1	NULL
)	NULL
4	NULL
(	NULL
1	NULL
)	NULL
IFN-y	NULL
(	NULL
200	NULL
U/ml	NULL
)	NULL
72	NULL
(	NULL
26	NULL
)	NULL
77	NULL
(	NULL
12	NULL
)	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
57	NULL
(	NULL
15	NULL
)	NULL
65	NULL
(	NULL
22	NULL
)	NULL
RA	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
33	NULL
(	NULL
1	NULL
)	NULL
36	NULL
(	NULL
8	NULL
)	NULL
Cells	NULL
were	NULL
differentiated	NULL
with	NULL
indicated	NULL
agents	NULL
for	NULL
3	NULL
days	NULL
and	NULL
assayed	NULL
by	NULL
flow	NULL
cytometry	NULL
for	NULL
MAC-1/CD11b	NULL
and	NULL
HLA-DR	NULL
cell	NULL
surface	NULL
expression	NULL
(	NULL
%	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Mean	NULL
fluorescence	NULL
intensity	NULL
is	NULL
shown	NULL
in	NULL
parentheses	NULL
.	NULL

reported	NULL
(	NULL
16	NULL
)	NULL
.	NULL

HL-60	NULL
cells	NULL
treated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
IFN-y	NULL
show	NULL
no	NULL
variation	NULL
of	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
mRNA	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Exposure	NULL
to	NULL
RA	NULL
and	NULL
DMSO	NULL
for	NULL
3	NULL
days	NULL
results	NULL
in	NULL
a	NULL
dramatic	NULL
decrease	NULL
in	NULL
4E-BP1	NULL
mRNA	NULL
to	NULL
a	NULL
hardly	NULL
detectable	NULL
level	NULL
,	NULL
whereas	NULL
no	NULL
apparent	NULL
modification	NULL
of	NULL
4E-BP2	NULL
mRNA	NULL
level	NULL
was	NULL
detected	NULL
,	NULL
as	NULL
quantified	NULL
by	NULL
densitometry	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Hybridization	NULL
of	NULL
the	NULL
blot	NULL
with	NULL
an	NULL
actin	NULL
cDNA	NULL
probe	NULL
demonstrates	NULL
that	NULL
equivalent	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

--	NULL
®	NULL
--	NULL
_	NULL
Control	NULL
_o_	NULL
.	NULL

RA	NULL
-A-	NULL
_	NULL
IFN-y	NULL
--	NULL
O	NULL
--	NULL
_	NULL
PMA	NULL
ro	NULL
4	NULL
to	NULL
a	NULL
&	NULL
n	NULL
o	NULL
Time	NULL
Course	NULL
(	NULL
day	NULL
)	NULL
A	NULL
207	NULL
€	NULL
o	NULL
x	NULL
s	NULL
10	NULL
{	NULL
5	NULL
a	NULL
E	NULL
2	NULL
%	NULL
O	NULL
FIGURE	NULL
6	NULL
.	NULL

Assessment	NULL
of	NULL
U-937	NULL
differentiation	NULL
.	NULL

°	NULL
0	NULL
'	NULL
U-937	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
an	NULL
initial	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
without	NULL
or	NULL
with	NULL
200	NULL
U/ml	NULL
IFN-y	NULL
,	NULL
5	NULL
ng/ml	NULL
PMA	NULL
,	NULL
or	NULL
1	NULL
uM	NULL
RA	NULL
,	NULL
and	NULL
were	NULL
cultured	NULL
for	NULL
5	NULL
days	NULL
without	NULL
any	NULL
change	NULL
of	NULL
media	NULL
.	NULL

A	NULL
,	NULL
Cell	NULL
growth	NULL
curves	NULL
of	NULL
un-	NULL
B	NULL
treated	NULL
and	NULL
treated	NULL
U-937	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
counted	NULL
after	NULL
3	NULL
and	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
.	NULL

The	NULL
shown	NULL
concentrations	NULL
a	NULL
are	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
,	NULL
and	NULL
the	NULL
error	NULL
bars	NULL
indicate	NULL
the	NULL
SD	NULL
from	NULL
the	NULL
mean	NULL
.	NULL

B	NULL
,	NULL
Morphology	NULL
of	NULL
uninduced	NULL
and	NULL
induced	NULL
U-937	NULL
cells	NULL
.	NULL

Photomicrographs	NULL
of	NULL
May-Griinwald-stained	NULL
cytospin	NULL
preparations	NULL
are	NULL
recorded	NULL
from	NULL
the	NULL
following	NULL
sources	NULL
:	NULL
U-937	NULL
cells	NULL
treated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
control	NULL
medium	NULL
(	NULL
a	NULL
)	NULL
;	NULL
with	NULL
RA	NULL
(	NULL
b	NULL
)	NULL
,	NULL
with	NULL
IFN-y	NULL
(	NULL
c	NULL
)	NULL
;	NULL
or	NULL
with	NULL
PMA	NULL
(	NULL
d	NULL
)	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
3496	NULL
REPRESSORS	NULL
OF	NULL
TRANSLATION	NULL
AND	NULL
MYELOID	NULL
DIFFERENTIATION	NULL
FIGURE	NULL
7	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
in	NULL
differentiated	NULL
U-937	NULL
cells	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
S	NULL
seeded	NULL
at	NULL
an	NULL
initial	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
E	NULL
100	NULL
in	NULL
medium	NULL
containing	NULL
serum	NULL
(	NULL
5	NULL
%	NULL
)	NULL
without	NULL
or	NULL
8.	NULL
with	NULL
200	NULL
U/ml	NULL
IFN-y	NULL
,	NULL
5	NULL
ng/ml	NULL
PMA	NULL
,	NULL
or	NULL
1	NULL
wM	NULL
é	NULL
3G	NULL
RA	NULL
.	NULL

At	NULL
3	NULL
and	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
10°	NULL
cells/ml	NULL
‘	NULL
E	NULL
’	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
in	NULL
methionine-free	NULL
8	NULL
8	NULL
medium	NULL
,	NULL
then	NULL
[	NULL
°*S	NULL
]	NULL
methionine	NULL
(	NULL
100	NULL
mCi	NULL
)	NULL
was	NULL
g	NULL
``	NULL
0	NULL
added	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
radioactivity	NULL
incorporated	NULL
'	NULL
C	NULL
2\i	NULL
into	NULL
TCA-precipitable	NULL
material	NULL
was	NULL
measured	NULL
.	NULL

©	NULL
The	NULL
effects	NULL
of	NULL
the	NULL
different	NULL
agents	NULL
are	NULL
expressed	NULL
g	NULL
as	NULL
percentage	NULL
of	NULL
the	NULL
control	NULL
.	NULL

The	NULL
experiment	NULL
&	NULL
was	NULL
conducted	NULL
two	NULL
times	NULL
,	NULL
and	NULL
the	NULL
error	NULL
bars	NULL
in-	NULL
-C	NULL
dicate	NULL
the	NULL
SD	NULL
from	NULL
the	NULL
mean	NULL
.	NULL

o	NULL
Thus	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
general	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
,	NULL
but	NULL
different	NULL
terminal	NULL
differentiation	NULL
stages	NULL
,	NULL
IFN-y	NULL
or	NULL
PMA	NULL
and	NULL
RA	NULL
or	NULL
DMSO	NULL
regulate	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
functions	NULL
differently	NULL
.	NULL

During	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
along	NULL
the	NULL
granulocytic	NULL
pathway	NULL
,	NULL
expression	NULL
of	NULL
4E-BP2	NULL
protein	NULL
is	NULL
strongly	NULL
increased	NULL
with	NULL
no	NULL
modification	NULL
of	NULL
its	NULL
mRNA	NULL
level	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
4E-BP1	NULL
protein	NULL
and	NULL
mRNA	NULL
is	NULL
decreased	NULL
.	NULL

These	NULL
results	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
4E-BP1	NULL
expression	NULL
is	NULL
controlled	NULL
primarily	NULL
at	NULL
a	NULL
transcrip-tional	NULL
level	NULL
,	NULL
whereas	NULL
4E-BP2	NULL
expression	NULL
is	NULL
regulated	NULL
at	NULL
a	NULL
posttranscriptional	NULL
level	NULL
.	NULL

Assessment	NULL
of	NULL
U-937	NULL
cell	NULL
differentiation	NULL
To	NULL
confirm	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
4E-BP	NULL
and	NULL
4E-BP2	NULL
expression	NULL
observed	NULL
during	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
is	NULL
specific	NULL
to	NULL
the	NULL
differentiation	NULL
pathway	NULL
and	NULL
not	NULL
to	NULL
the	NULL
particular	NULL
inducers	NULL
or	NULL
cells	NULL
used	NULL
in	NULL
our	NULL
experiments	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
during	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
.	NULL

The	NULL
monoblastic	NULL
U-937	NULL
cells	NULL
are	NULL
arrested	NULL
in	NULL
an	NULL
advanced	NULL
stage	NULL
of	NULL
differentiation	NULL
,	NULL
and	NULL
therefore	NULL
,	NULL
treatment	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
any	NULL
of	NULL
the	NULL
four	NULL
induc-ers	NULL
,	NULL
IFN-y	NULL
,	NULL
PMA	NULL
,	NULL
RA	NULL
,	NULL
or	NULL
DMSO	NULL
,	NULL
carries	NULL
their	NULL
differentiation	NULL
into	NULL
monocytes/macrophages	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

We	NULL
treated	NULL
the	NULL
U-937	NULL
cells	NULL
for	NULL
3	NULL
and	NULL
5	NULL
days	NULL
with	NULL
IFN-y	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
RA	NULL
,	NULL
and	NULL
monitored	NULL
their	NULL
differentiation	NULL
stage	NULL
by	NULL
the	NULL
same	NULL
three	NULL
criteria	NULL
as	NULL
used	NULL
for	NULL
HL-60	NULL
cells	NULL
:	NULL
4E-BP1	NULL
-	NULL
>	NULL
--	NULL
%	NULL
4E-BP2	NULL
|	NULL
|	NULL
Actin	NULL
|	NULL
<	NULL
<	NULL
--	NULL
_	NULL
ra	NULL
»	NULL
_	NULL
apo	NULL
»	NULL
_	NULL
Gp	NULL
»	NULL
|	NULL
C	NULL
d3	NULL
dS	NULL
d3	NULL
dS	NULL
d3	NULL
dS	NULL
RA	NULL
IFN-y	NULL
PMA	NULL
FIGURE	NULL
8	NULL
.	NULL

Expression	NULL
of	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
proteins	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
.	NULL

U-937	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
an	NULL
initial	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
medium	NULL
containing	NULL
serum	NULL
(	NULL
5	NULL
%	NULL
)	NULL
without	NULL
or	NULL
with	NULL
200	NULL
U/ml	NULL
IFN-y	NULL
,	NULL
5	NULL
ng/ml	NULL
PMA	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
RA	NULL
.	NULL

At	NULL
3	NULL
and	NULL
5	NULL
days	NULL
(	NULL
d3	NULL
and	NULL
d5	NULL
)	NULL
of	NULL
culture	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
total	NULL
protein	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
,	NULL
using	NULL
rabbit	NULL
anti-4E-BP1	NULL
(	NULL
1:1000	NULL
)	NULL
or	NULL
rabbit	NULL
anti-4E-BP2	NULL
(	NULL
1:1000	NULL
)	NULL
Abs	NULL
,	NULL
followed	NULL
by	NULL
chemoluminescence	NULL
detection	NULL
.	NULL

&	NULL
A	NULL
Control	NULL
C	NULL
RA	NULL
E	NULL
IFN-y	NULL
PMA	NULL
Days	NULL
of	NULL
culture	NULL
cell	NULL
proliferation	NULL
,	NULL
morphology	NULL
,	NULL
and	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
specific	NULL
markers	NULL
.	NULL

Following	NULL
treatment	NULL
with	NULL
each	NULL
agent	NULL
,	NULL
cell	NULL
proliferation	NULL
was	NULL
strongly	NULL
reduced	NULL
at	NULL
3	NULL
and	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Morphology	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
analyzed	NULL
by	NULL
the	NULL
method	NULL
of	NULL
May-Griinwald	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
different	NULL
treatments	NULL
resulted	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
U-937	NULL
cell	NULL
differentiation	NULL
toward	NULL
a	NULL
more	NULL
mature	NULL
state	NULL
with	NULL
major	NULL
characteristic	NULL
of	NULL
monocytes/macrophages	NULL
:	NULL
large	NULL
cytoplasms	NULL
with	NULL
vacuolizations	NULL
,	NULL
particularly	NULL
in	NULL
the	NULL
PMA-induced	NULL
cells	NULL
,	NULL
nuclear	NULL
chromatin	NULL
not	NULL
condensed	NULL
,	NULL
and	NULL
persistence	NULL
of	NULL
nucleoli	NULL
.	NULL

Similar	NULL
morphologies	NULL
were	NULL
observed	NULL
after	NULL
5	NULL
days	NULL
of	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
also	NULL
controlled	NULL
by	NULL
FACScan	NULL
analysis	NULL
of	NULL
specific	NULL
marquers	NULL
,	NULL
CD11b	NULL
and	NULL
HLA-DR	NULL
(	NULL
Table	NULL
ID	NULL
)	NULL
.	NULL

Differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
induced	NULL
by	NULL
RA	NULL
,	NULL
IFN-y	NULL
,	NULL
and	NULL
PMA	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
of	NULL
the	NULL
two	NULL
surface	NULL
Ag	NULL
expression	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
into	NULL
monocytes/macrophages	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Protein	NULL
synthesis	NULL
rates	NULL
in	NULL
undifferentiated	NULL
and	NULL
differentiated	NULL
U-937	NULL
cells	NULL
We	NULL
analyzed	NULL
protein	NULL
synthesis	NULL
rates	NULL
during	NULL
differentiation	NULL
of	NULL
the	NULL
U-937	NULL
cells	NULL
by	NULL
metabolic	NULL
labeling	NULL
of	NULL
cells	NULL
with	NULL
and	NULL
incorporation	NULL
rates	NULL
were	NULL
measured	NULL
3	NULL
and	NULL
5	NULL
days	NULL
after	NULL
stimulation	NULL
.	NULL

Protein	NULL
synthesis	NULL
was	NULL
strongly	NULL
inhibited	NULL
in	NULL
U-937	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
into	NULL
monocytes/macrophages	NULL
after	NULL
IFN-y	NULL
and	NULL
PMA	NULL
treatments	NULL
for	NULL
5	NULL
days	NULL
(	NULL
75	NULL
and	NULL
90	NULL
%	NULL
inhibition	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

A	NULL
lesser	NULL
extent	NULL
of	NULL
inhibition	NULL
was	NULL
obtained	NULL
following	NULL
RA	NULL
treatment	NULL
for	NULL
5	NULL
days	NULL
(	NULL
35	NULL
%	NULL
inhibition	NULL
)	NULL
.	NULL

Slight	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
was	NULL
observed	NULL
with	NULL
IFN-y	NULL
and	NULL
RA	NULL
after	NULL
3	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
whereas	NULL
inhibition	NULL
was	NULL
already	NULL
very	NULL
strong	NULL
after	NULL
3	NULL
days	NULL
of	NULL
treatment	NULL
with	NULL
PMA	NULL
.	NULL

4E-BPI1	NULL
and	NULL
4E-BP2	NULL
expression	NULL
during	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
We	NULL
analyzed	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
proteins	NULL
by	NULL
Western	NULL
blotting	NULL
during	NULL
U-937	NULL
cell	NULL
differentiation	NULL
induced	NULL
by	NULL
IFN-y	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
RA	NULL
.	NULL

As	NULL
in	NULL
HL-60	NULL
cells	NULL
,	NULL
three	NULL
isoforms	NULL
of	NULL
4E-BP1	NULL
(	NULL
indicated	NULL
by	NULL
the	NULL
arrows	NULL
;	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
were	NULL
detected	NULL
following	NULL
immunoblotting	NULL
of	NULL
extracts	NULL
from	NULL
untreated	NULL
U-937	NULL
cells	NULL
.	NULL

RA	NULL
as	NULL
well	NULL
as	NULL
IFN-y	NULL
and	NULL
PMA	NULL
induced	NULL
a	NULL
dephosphorylation	NULL
of	NULL
4E-BP1	NULL
.	NULL

The	NULL
dephosphorylation	NULL
of	NULL
4E-BP1	NULL
was	NULL
strong	NULL
after	NULL
3	NULL
days	NULL
and	NULL
complete	NULL
after	NULL
5	NULL
days	NULL
.	NULL

4E-BP2	NULL
expression	NULL
is	NULL
low	NULL
in	NULL
U-937	NULL
cells	NULL
,	NULL
and	NULL
no	NULL
increase	NULL
,	NULL
but	NULL
rather	NULL
a	NULL
slight	NULL
decrease	NULL
,	NULL
was	NULL
observed	NULL
during	NULL
the	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
by	NULL
the	NULL
three	NULL
inducers	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Therefore	NULL
,	NULL
dephosphorylation	NULL
of	NULL
4E-BP1	NULL
is	NULL
a	NULL
mechanism	NULL
specific	NULL
to	NULL
the	NULL
monocytic/macrophage	NULL
differentiation	NULL
pathway	NULL
and	NULL
not	NULL
specific	NULL
to	NULL
the	NULL
inducers	NULL
used	NULL
,	NULL
whereas	NULL
increase	NULL
in	NULL
4E-BP2	NULL
protein	NULL
expression	NULL
is	NULL
a	NULL
mechanism	NULL
specific	NULL
to	NULL
the	NULL
granulocytic	NULL
differentiation	NULL
pathway	NULL
and	NULL
not	NULL
specific	NULL
to	NULL
the	NULL
inducers	NULL
used	NULL
.	NULL

Discussion	NULL
There	NULL
is	NULL
considerable	NULL
flexibility	NULL
in	NULL
the	NULL
myeloid	NULL
differentiation	NULL
pro-gram	NULL
,	NULL
and	NULL
the	NULL
biological	NULL
functions	NULL
of	NULL
the	NULL
cells	NULL
comprising	NULL
mono-nuclear	NULL
phagocytes	NULL
depend	NULL
on	NULL
the	NULL
successful	NULL
completion	NULL
of	NULL
the	NULL
differentiation	NULL
pathway	NULL
from	NULL
immature	NULL
precursor	NULL
cells	NULL
to	NULL
the	NULL
mature	NULL
macrophage	NULL
.	NULL

Control	NULL
of	NULL
gene	NULL
expression	NULL
can	NULL
result	NULL
in	NULL
expression	NULL
of	NULL
specific	NULL
cell	NULL
functions	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
translation	NULL
inhibitor	NULL
4E-BP1	NULL
is	NULL
specific	NULL
to	NULL
monocytes/macro-phages	NULL
.	NULL

Dephosphorylation	NULL
of	NULL
4E-BPI1	NULL
occurs	NULL
during	NULL
the	NULL
process	NULL
of	NULL
differentiation	NULL
,	NULL
suggesting	NULL
a	NULL
concomitant	NULL
increase	NULL
in	NULL
its	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
4E-BP1	NULL
is	NULL
down-regulated	NULL
in	NULL
granulo-cytes	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
4E-BP2	NULL
is	NULL
strongly	NULL
increased	NULL
during	NULL
differentiation	NULL
of	NULL
cells	NULL
along	NULL
the	NULL
granulocytic	NULL
pathway	NULL
.	NULL

These	NULL
regulations	NULL
may	NULL
be	NULL
responsible	NULL
at	NULL
least	NULL
in	NULL
part	NULL
for	NULL
the	NULL
reduction	NULL
of	NULL
protein	NULL
synthesis	NULL
we	NULL
observed	NULL
during	NULL
differentiation	NULL
of	NULL
the	NULL
myeloid	NULL
cells	NULL
.	NULL

This	NULL
reduction	NULL
of	NULL
protein	NULL
synthesis	NULL
correlates	NULL
well	NULL
with	NULL
the	NULL
well-known	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
during	NULL
the	NULL
differentiation	NULL
process	NULL
.	NULL

More	NULL
interestingly	NULL
,	NULL
our	NULL
results	NULL
show	NULL
that	NULL
inhibition	NULL
of	NULL
translation	NULL
occurs	NULL
through	NULL
different	NULL
events	NULL
during	NULL
monocytic/macrophage	NULL
differentiation	NULL
pathway	NULL
or	NULL
during	NULL
the	NULL
granulocytic	NULL
pathway	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
a	NULL
general	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
,	NULL
expression	NULL
of	NULL
4E-BP1	NULL
or	NULL
4E-BP2	NULL
could	NULL
confer	NULL
different	NULL
translational	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
leading	NULL
to	NULL
these	NULL
two	NULL
differentiation	NULL
pathways	NULL
.	NULL

It	NULL
would	NULL
be	NULL
of	NULL
great	NULL
interest	NULL
to	NULL
determine	NULL
the	NULL
existence	NULL
of	NULL
specific	NULL
genes	NULL
whose	NULL
translation	NULL
may	NULL
be	NULL
regulated	NULL
specifically	NULL
or	NULL
predominantly	NULL
by	NULL
4E-BP1	NULL
or	NULL
by	NULL
4E-BP2	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
has	NULL
to	NULL
be	NULL
considered	NULL
that	NULL
nondividing	NULL
mature	NULL
macrophages	NULL
become	NULL
good	NULL
translators	NULL
of	NULL
specific	NULL
mRNAs	NULL
such	NULL
as	NULL
cytokines	NULL
.	NULL

Our	NULL
results	NULL
would	NULL
therefore	NULL
suggest	NULL
that	NULL
translation	NULL
of	NULL
these	NULL
particular	NULL
cytokines	NULL
may	NULL
implicate	NULL
a	NULL
different	NULL
mechanism	NULL
,	NULL
potentially	NULL
independent	NULL
on	NULL
4E-BP	NULL
functions	NULL
.	NULL

These	NULL
hypotheses	NULL
are	NULL
currently	NULL
under	NULL
investigation	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
4E-BP1	NULL
is	NULL
a	NULL
major	NULL
target	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
(	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
is	NULL
not	NULL
necessary	NULL
to	NULL
induce	NULL
4E-BP1	NULL
phosphorylation	NULL
(	NULL
20-23	NULL
)	NULL
,	NULL
and	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
dephosphorylation	NULL
of	NULL
4E-BP1	NULL
occurs	NULL
following	NULL
rapamycin	NULL
treatment	NULL
of	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
phosphorylation	NULL
of	NULL
4E-BPI1	NULL
is	NULL
mediated	NULL
by	NULL
mTOR	NULL
(	NULL
mammalian	NULL
target	NULL
of	NULL
rapamycin	NULL
,	NULL
also	NULL
called	NULL
FRAP	NULL
or	NULL
RAFT1	NULL
)	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
family	NULL
of	NULL
phos-phoinositide	NULL
3-kinase-related	NULL
kinases	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
fact	NULL
that	NULL
dephosphorylation	NULL
of	NULL
4E-BP1	NULL
induced	NULL
by	NULL
IFN-y	NULL
is	NULL
slow	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
mTOR	NULL
in	NULL
IFN-y	NULL
signaling	NULL
should	NULL
be	NULL
investigated	NULL
.	NULL

Up-regulation	NULL
of	NULL
4E-BP2	NULL
during	NULL
granulocyte	NULL
differentiation	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
,	NULL
as	NULL
it	NULL
occurs	NULL
after	NULL
2	NULL
days	NULL
of	NULL
treatment	NULL
,	NULL
preceding	NULL
the	NULL
morphology	NULL
changes	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
an	NULL
increase	NULL
in	NULL
4E-BP2	NULL
protein	NULL
expression	NULL
in	NULL
cellular	NULL
clones	NULL
resistant	NULL
to	NULL
the	NULL
granulocytic	NULL
differentiation	NULL
induced	NULL
by	NULL
RA	NULL
(	NULL
A.G.	NULL
and	NULL
L.B	NULL
.	NULL

,	NULL
personnal	NULL
observations	NULL
)	NULL
.	NULL

The	NULL
up-regulation	NULL
of	NULL
4E-BP2	NULL
protein	NULL
is	NULL
not	NULL
due	NULL
to	NULL
a	NULL
RA-response	NULL
element	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
4E-BP2	NULL
gene	NULL
,	NULL
as	NULL
no	NULL
induction	NULL
of	NULL
4E-BP2	NULL
mRNA	NULL
was	NULL
observed	NULL
,	NULL
suggesting	NULL
a	NULL
posttranscriptional	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Because	NULL
the	NULL
effect	NULL
of	NULL
RA	NULL
on	NULL
differentiation	NULL
of	NULL
promyelocytic	NULL
leukemic	NULL
cells	NULL
is	NULL
now	NULL
used	NULL
clinically	NULL
in	NULL
the	NULL
therapy	NULL
of	NULL
these	NULL
leukemias	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
it	NULL
would	NULL
be	NULL
of	NULL
great	NULL
interest	NULL
to	NULL
analyze	NULL
expression	NULL
of	NULL
4E-BP2	NULL
in	NULL
3497	NULL
leukemias	NULL
and	NULL
to	NULL
investigate	NULL
the	NULL
consequence	NULL
of	NULL
modifying	NULL
4E-BP2	NULL
gene	NULL
expression	NULL
in	NULL
these	NULL
tumor	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
D.	NULL
Rouillard	NULL
for	NULL
her	NULL
valuable	NULL
help	NULL
and	NULL
B.	NULL
Bauvois	NULL
for	NULL
advice	NULL
.	NULL

We	NULL
also	NULL
acknowledge	NULL
A.-C.	NULL
Gingras	NULL
for	NULL
providing	NULL
Abs	NULL
to	NULL
4E-BP1	NULL
and	NULL
4E-BP2	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Sachs	NULL
,	NULL
L.	NULL
1996	NULL
.	NULL

The	NULL
control	NULL
of	NULL
hematopoiesis	NULL
and	NULL
leukemia	NULL
:	NULL
from	NULL
basic	NULL
biology	NULL
to	NULL
the	NULL
clinic	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:4742	NULL
.	NULL

2	NULL
.	NULL

Sonenberg	NULL
,	NULL
N.	NULL
1996.	NULL
mRNA	NULL
5	NULL
'	NULL
cap-binding	NULL
protein	NULL
eIF4E	NULL
and	NULL
control	NULL
of	NULL
cell	NULL
growth	NULL
.	NULL

In	NULL
Translational	NULL
Control	NULL
.	NULL

J.	NULL
W.	NULL
B.	NULL
Hershey	NULL
,	NULL
M.	NULL
B.	NULL
Mathews	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
,	NULL
eds	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
.	NULL

NY	NULL
.	NULL

3	NULL
.	NULL

Morris	NULL
,	NULL
D.	NULL
1995	NULL
.	NULL

Growth	NULL
control	NULL
of	NULL
translation	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

51:339	NULL
.	NULL

4	NULL
.	NULL

Shatkin	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

1985.	NULL
mRNA	NULL
cap	NULL
binding	NULL
proteins	NULL
:	NULL
essential	NULL
factors	NULL
for	NULL
translation	NULL
initiation	NULL
.	NULL

Cell	NULL
40:223	NULL
.	NULL

5	NULL
.	NULL

Pause	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
J.	NULL
Belsham	NULL
,	NULL
A.	NULL
C.	NULL
Gingras	NULL
,	NULL
O.	NULL
Donze	NULL
,	NULL
T.	NULL
A.	NULL
Lin	NULL
,	NULL
J.	NULL
C.	NULL
Lawrence	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
.	NULL

1994	NULL
.	NULL

Insulin-dependent	NULL
stimulation	NULL
of	NULL
protein	NULL
synthesis	NULL
by	NULL
phosphorylation	NULL
of	NULL
a	NULL
regulator	NULL
of	NULL
5'-cap	NULL
function	NULL
.	NULL

Nature	NULL
371:762	NULL
.	NULL

6	NULL
.	NULL

Lin	NULL
,	NULL
T.-A	NULL
.	NULL

,	NULL
X.	NULL
Kong	NULL
,	NULL
T.	NULL
A.	NULL
J.	NULL
Haystead	NULL
,	NULL
A	NULL
.	NULL

Pause	NULL
,	NULL
G.	NULL
Belsham	NULL
,	NULL
N.	NULL
Sonenberg	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Lawrence	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

PHAS-I	NULL
as	NULL
a	NULL
link	NULL
between	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
and	NULL
translation	NULL
initiation	NULL
.	NULL

Science	NULL
266:653	NULL
.	NULL

7	NULL
.	NULL

Hu	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Pang	NULL
,	NULL
X.	NULL
Kong	NULL
,	NULL
M.	NULL
Velleca	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Lawrence	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
tissue	NULL
distribution	NULL
of	NULL
PHAS-I	NULL
,	NULL
an	NULL
intracellular	NULL
target	NULL
for	NULL
insulin	NULL
and	NULL
growth	NULL
factors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3730	NULL
.	NULL

8	NULL
.	NULL

Beretta	NULL
,	NULL
L.	NULL
,	NULL
A.-G.	NULL
Gingras	NULL
,	NULL
Y.	NULL
Svitkin	NULL
,	NULL
M.	NULL
N.	NULL
Hall	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
.	NULL

1996	NULL
.	NULL

Rapamycin	NULL
blocks	NULL
the	NULL
phosphorylation	NULL
of	NULL
4E-BP1	NULL
and	NULL
inhibits	NULL
cap-dependent	NULL
initiation	NULL
of	NULL
translation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:658	NULL
.	NULL

9	NULL
.	NULL

Rousseau	NULL
,	NULL
D.	NULL
,	NULL
A.-G.	NULL
Gingras	NULL
,	NULL
A	NULL
.	NULL

Pause	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
eIF4E-binding	NULL
proteins	NULL
1	NULL
and	NULL
2	NULL
are	NULL
negative	NULL
regulators	NULL
of	NULL
cell	NULL
growth	NULL
.	NULL

Oncogene	NULL
13	NULL
:	NULL
2415	NULL
.	NULL

10	NULL
.	NULL

Beretta	NULL
,	NULL
L.	NULL
,	NULL
N.	NULL
G.	NULL
Singer	NULL
,	NULL
R.	NULL
Hinderer	NULL
,	NULL
A.-G.	NULL
Gingras	NULL
,	NULL
B.	NULL
Richardson	NULL
,	NULL
S.	NULL
M.	NULL
Hanash	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
.	NULL

1998	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
translation	NULL
and	NULL
eIF4E	NULL
phosphorylation	NULL
during	NULL
human	NULL
thymocyte	NULL
maturation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:3269	NULL
.	NULL

11	NULL
.	NULL

Harris	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
P.	NULL
Ralph	NULL
.	NULL

1985	NULL
.	NULL

Human	NULL
leukemic	NULL
models	NULL
of	NULL
myelomonocytic	NULL
development	NULL
:	NULL
a	NULL
review	NULL
of	NULL
the	NULL
HL-60	NULL
and	NULL
U-937	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

37:407	NULL
.	NULL

12	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
1970	NULL
.	NULL

Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
227:680	NULL
.	NULL

13	NULL
.	NULL

Chrigwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
A.	NULL
E.	NULL
Przybyla	NULL
,	NULL
R.	NULL
J.	NULL
MacDonald	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1979	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribo-nuclease	NULL
.	NULL

Biochemistry	NULL
18:5294	NULL
.	NULL

14	NULL
.	NULL

Collins	NULL
,	NULL
S.	NULL
T.	NULL
1987	NULL
.	NULL

The	NULL
HL-60	NULL
promyelotic	NULL
leukemia	NULL
cell	NULL
line	NULL
:	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
cellular	NULL
oncogene	NULL
expression	NULL
.	NULL

Blood	NULL
70:1233	NULL
.	NULL

15	NULL
.	NULL

Liibbert	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
Herrmann	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

1991	NULL
.	NULL

Expression	NULL
and	NULL
regulation	NULL
of	NULL
myeloid-specific	NULL
gene	NULL
in	NULL
normal	NULL
and	NULL
leukemic	NULL
myeloid	NULL
cells	NULL
.	NULL

Blood	NULL
77:909	NULL
.	NULL

16	NULL
.	NULL

Tsukiyama-Kohbara	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
M.	NULL
Vidal	NULL
,	NULL
A.	NULL
C.	NULL
Gingras	NULL
,	NULL
T.	NULL
W.	NULL
Glover	NULL
,	NULL
S.	NULL
M.	NULL
Hanash	NULL
,	NULL
H.	NULL
Heng	NULL
,	NULL
and	NULL
N.	NULL
Sonenberg	NULL
.	NULL

1996	NULL
.	NULL

Tissue	NULL
distribution	NULL
,	NULL
genomic	NULL
structure	NULL
and	NULL
chromosome	NULL
mapping	NULL
of	NULL
mouse	NULL
and	NULL
human	NULL
eukaryotic	NULL
initiation	NULL
factor	NULL
4B-bind-ing	NULL
proteins	NULL
1	NULL
and	NULL
2	NULL
.	NULL

Genomics	NULL
38:353	NULL
.	NULL

17	NULL
.	NULL

Olsson	NULL
,	NULL
L	NULL
L.	NULL
,	NULL
and	NULL
T.	NULL
R.	NULL
Breitman	NULL
.	NULL

1982	NULL
.	NULL

Induction	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
U-937	NULL
by	NULL
retinoic	NULL
acid	NULL
and	NULL
cyclic	NULL
adenosine	NULL
3	NULL
'	NULL
:	NULL
5'-monophosphate-inducing	NULL
agents	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

42:3924	NULL
.	NULL

18	NULL
.	NULL

Walz	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
C.	NULL
Malm	NULL
,	NULL
B.	NULL
K.	NULL
Nishikawa	NULL
,	NULL
K.	NULL
Willander	NULL
,	NULL
S.	NULL
Wingren	NULL
,	NULL
and	NULL
A.	NULL
Wasteson	NULL
.	NULL

1995	NULL
.	NULL

Production	NULL
of	NULL
transforming	NULL
growth	NULL
factor	NULL
a	NULL
by	NULL
human	NULL
leukemia	NULL
cells	NULL
(	NULL
HL-60	NULL
and	NULL
U-937	NULL
)	NULL
during	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Leukemia	NULL
9:671	NULL
.	NULL

19	NULL
.	NULL

Oberg	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Botling	NULL
,	NULL
and	NULL
K.	NULL
Nilsson	NULL
.	NULL

1993	NULL
.	NULL

Macrophages	NULL
and	NULL
the	NULL
cytokine	NULL
net-work	NULL
.	NULL

Transplant	NULL
.	NULL

Proc	NULL
.	NULL

25:2044	NULL
.	NULL

20	NULL
.	NULL

Von	NULL
Manteuffel	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
A.-G.	NULL
Gingras	NULL
,	NULL
X.-F.	NULL
Ming	NULL
,	NULL
N.	NULL
Sonenberg	NULL
,	NULL
and	NULL
G.	NULL
Thomas	NULL
.	NULL

1996	NULL
.	NULL

4E-BP1	NULL
phosphorylation	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
FRAP-p70S6K	NULL
pathway	NULL
and	NULL
is	NULL
independent	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:4076	NULL
.	NULL

21	NULL
.	NULL

Diggle	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
S.	NULL
K.	NULL
Moule	NULL
,	NULL
M.	NULL
B.	NULL
Avison	NULL
,	NULL
A.	NULL
Flynn	NULL
,	NULL
E.	NULL
J.	NULL
Foulstone	NULL
,	NULL
C.	NULL
G.	NULL
Proud	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Denton	NULL
.	NULL

1996	NULL
.	NULL

Both	NULL
rapamycin-sensitive	NULL
and	NULL
-insensitive	NULL
pathways	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
initiation	NULL
factor-4E-binding	NULL
protein	NULL
(	NULL
4E-BP1	NULL
)	NULL
in	NULL
response	NULL
to	NULL
insulin	NULL
in	NULL
rat	NULL
epididymal	NULL
fat-cells	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

316:447	NULL
.	NULL

22	NULL
.	NULL

Fleurent	NULL
,	NULL
M.	NULL
,	NULL
A.-C.	NULL
Gingras	NULL
,	NULL
N.	NULL
Sonenberg	NULL
,	NULL
and	NULL
S.	NULL
Meloche	NULL
.	NULL

1997	NULL
.	NULL

Angiotensin	NULL
TI	NULL
stimulates	NULL
phosphorylation	NULL
of	NULL
the	NULL
translational	NULL
repressors	NULL
4E-binding	NULL
protein	NULL
1	NULL
by	NULL
a	NULL
mitogen-activated	NULL
protein	NULL
kinase-independent	NULL
mechanism	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:4006	NULL
.	NULL

23	NULL
.	NULL

Gingras	NULL
,	NULL
A.-C.	NULL
,	NULL
S.	NULL
G.	NULL
Kennedy	NULL
,	NULL
M.	NULL
A.	NULL
O'Leary	NULL
,	NULL
N.	NULL
Sonenberg	NULL
,	NULL
and	NULL
N.	NULL
Hay	NULL
.	NULL

1998	NULL
.	NULL

4E-BP1	NULL
,	NULL
a	NULL
repressor	NULL
of	NULL
mRNA	NULL
translation	NULL
,	NULL
is	NULL
phosphorylated	NULL
and	NULL
inactivated	NULL
by	NULL
the	NULL
Akt	NULL
(	NULL
PKB	NULL
)	NULL
signaling	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

12:502	NULL
.	NULL

24	NULL
.	NULL

Brown	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Schreiber	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
signaling	NULL
pathway	NULL
to	NULL
translational	NULL
control	NULL
.	NULL

Cell	NULL
86:517	NULL
.	NULL

25	NULL
.	NULL

Warrell	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
H.	NULL
De	NULL
The	NULL
,	NULL
Z.	NULL
Y.	NULL
Wang	NULL
,	NULL
and	NULL
L.	NULL
Degos	NULL
.	NULL

1993	NULL
.	NULL

Medical	NULL
progress	NULL
:	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

329:177	NULL
.	NULL

26	NULL
.	NULL

Drexler	NULL
,	NULL
H.	NULL
G.	NULL
,	NULL
H.	NULL
Quentmeier	NULL
,	NULL
R.	NULL
A.	NULL
F.	NULL
MacLeod	NULL
,	NULL
C.	NULL
C.	NULL
Uphoff	NULL
,	NULL
and	NULL
Z.-B	NULL
.	NULL

Hu	NULL
.	NULL

1995	NULL
.	NULL

Leukemia	NULL
cell	NULL
lines	NULL
:	NULL
in	NULL
vitro	NULL
models	NULL
for	NULL
the	NULL
study	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

19:681	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

